10-Years Follow-up of the EXAMINATION Trial
NCT04462315
Cardiovascular Diseases, Heart Disease
Seriate, Bergamo, Italy
View Trial DetailsNCT Number: NCT00001638
This study is directed at evaluating patients with "myocardial ischemia" or poor blood supply to the heart muscle due to coronary artery disease. The major objective of this study is to determine the level of safety and effectiveness of magnetic resonance imaging at diagnosing coronary artery disease.
In addition, this study will allow researchers at the National Institutes of Health to see a broad spectrum of disease, preserve clinical skills, and stimulate future ideas for clinical research....
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
This is a teaching protocol. It is in a format for training physicians in the laboratory in cardiovascular MRI techniques necessary for our research protocols. It helps provide experience necessary to develop and maintain our clinical expertise with cardiovascular MRI methods. It also provides physicians in the region access to this technology.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
for All Arms of the Protocol
Exclusion criteria
for All Arms of the Protocol:
Patients with a contraindication to MRI scanning will be excluded. These contraindications include patients with the following devices:
In addition the following patient groups will be excluded:
Furthermore, the following patient groups will be excluded from studies involving the administration of MRI contrast agents:
The eGFR will be used to estimate renal function if reported by the laboratory. Otherwise, estimated glomerular filtration rate (eGFR) can be based on the Modification of Diet in Renal Disease (MDRD) study equation (see below) in subjects with stable renal function. This formula is not applicable to patients with acute renal insufficiency:
eGFR (ml/min/l.73 m(2))= 175 x (serum creatinine)-l.l54 x (age)-0.203 x 0.742 (if the subject is female) x 1.212 (if the subject is black)
Additional Exclusion Criteria for Dobutamine MRI
Additional Exclusion Criteria for Vasodilator Stress MRI
National Heart, Lung, and Blood Institute (NHLBI)
Nih
Cardiovascular Magnetic Resonance Imaging
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04462315
Cardiovascular Diseases, Heart Disease
Seriate, Bergamo, Italy
View Trial DetailsNCT05484882
COVID-19, Cardiovascular Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT00178620
Acute Myocardial Infarction, Cardiovascular Diseases
Houston, Texas, United States
View Trial DetailsNCT00701220
Cardiomyopathies, Cardiomyopathy
Columbus, Ohio, United States
View Trial Details